CD8A and metabolic dysfunction-associated steatohepatitis: Notably, there was no difference in the transcriptome profiles of CD8+PD1+ T cells in NASH mice after anti-PD1 immunotherapy (Extended Data Fig. 6c), indicating that the number of T cells rather than their functional properties were changed.